Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

People with Lichen Planus have thicker carotid artery walls, but it's not solely due to Lichen Planus when other factors are considered.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Oral lichen planus is not linked to sex hormone levels.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Sex hormones do not cause oral lichen planus.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

GLPLS and LPP are variants of lichen planus.

Oral lichen planus can appear before lichen planopilaris.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Women with lichen planopilaris and frontal fibrosing alopecia often have other health issues like hypothyroidism and lupus.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Exosome treatment from stem cells improved hair regrowth and reduced scalp issues in a woman with lichen planopilaris.

Lichen planopilaris is rare, mostly affects older women, and is often linked to autoimmune diseases like lupus.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

EMS and EF both show similar skin and fascia changes, but EMS has more severe symptoms and nerve inflammation.

Thyroid disorders are linked to skin conditions like vitiligo and hair loss, so thyroid tests are recommended.